For the Inventor, By the Inventor

Enter assignee name

Salt Lake City, UT, United States of America

Recursion Pharmaceuticals, Inc.

USPTO Granted Patents = 48

% Expired Patents = 6.3

CIPO Patents = 3

EPO Patents = 1

Trademarks = 9

Forward Citations = 58

Loading Chart...

Loading Chart...

138 inventors (with patents filed for the assignee):

Mason L Victors (15 out of 15 patents)

Berton Allen Earnshaw (11 out of 11 patents)

Blake C Borgeson (8 out of 8 patents)

4. Marta Marie Fay (8 out of 8 patents)

5. Safiye Celik (8 out of 8 patents)

6. Conor Austin Forsman Tillinghast (7 out of 7 patents)

7. Jonathan Betts-Lacroix (6 out of 72 patents)

8. Scott Nielsen (6 out of 6 patents)

9. James Benjamin Taylor (6 out of 7 patents)

10. James Douglas Jensen (6 out of 8 patents)

11. Kyle Rollins Hansen (6 out of 6 patents)

12. Jacob Carter Cooper (6 out of 6 patents)

13. Seyhmus Guler (6 out of 6 patents)

14. Peter Foster McLean (6 out of 6 patents)

15. Laura R Schaevitz (5 out of 20 patents)

Core Competencies:

Machine Learning

Drug Discovery

Biological Mapping

Perturbation Data

Compound-Protein Models

High Throughput Screening

Digital Embedding

Causal Discovery

Pharmaceutical Composition

Heterocyclic Compounds

Experimental Design

48 patents: Sort by Forward Citations

1. 12738081 - Utilizing machine learning and digital embedding processes to generate digital maps of biology and user interfaces for evaluating map efficacy (2026-09-15),

2. 12737284 - Detecting analysis model compatibilities with complex experiment designs to generate experiment design and analysis model compatibility graphical user interfaces (2026-09-15),

3. 12729201 - MALT-1 modulators (2026-09-08),

4. 12663916 - Methods and user interfaces for designing cell-based screening assay experiments (2026-06-23),

5. 12657939 - Utilizing machine learning models to synthesize perturbation data to generate perturbation heatmap graphical user interfaces (2026-06-16),

6. 12651432 - Utilizing machine learning models to synthesize perturbation data to generate perturbation heatmap graphical user interfaces (2026-06-09),

7. 12645878 - Utilizing language machine learning models for autonomous executions of computerized tech-bio exploration tools (2026-06-02),

8. 12640230 - Active learning for discovering pairwise interactions via representation learning (2026-05-26),

9. 12609186 - Techniques for data-enabled drug discovery (2026-04-21),

10. 12572849 - Image embeddings via deep learning and adaptive batch normalization (2026-03-10),

11. 12540149 - Aromatic heterocyclic compound, pharmaceutical composition, and use thereof (2026-02-03),

12. 12533356 - Pyrazolopyrimidine compounds as adenosine receptor antagonists (2026-01-27),

13. 12528779 - Heterocyclic compounds and related methods (2026-01-20),

14. 12525324 - Active learning using coverage score (2026-01-13),

15. 12494266 - Utilizing a clinical-phenomics causal discovery framework to generate causal discovery predictions (2025-12-09),

Recursion Pharmaceuticals, Inc. is a biotechnology company based in Salt Lake City, Utah, specializing in drug discovery and development through advanced computational techniques and high-throughput biology. The organization leverages its proprietary platform to analyze cellular images and biological data, enabling the identification of novel therapeutics for various diseases. By integrating machine learning with biological insights, Recursion aims to accelerate the pace of drug development and improve patient outcomes across multiple therapeutic areas.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

48 Patents

#25 in Salt Lake City, UT

#85 in Utah

#7,275 in US

#14,527 in the World

Salt Lake City, UT, United States of America

Recursion Pharmaceuticals, Inc.

Forward Citations = 58

138 inventors:

Mason L Victors (15 out of 15 patents)

Berton Allen Earnshaw (11 out of 11 patents)

Blake C Borgeson (8 out of 8 patents)

4. Marta Marie Fay (8 out of 8 patents)

5. Safiye Celik (8 out of 8 patents)

Please report any incorrect information to [email protected]

Loading…